DPDA,
N,N-di-n-propyldopamine,
N,N-di-n-propyldopamine hydrobromide,
N,N-di-n-propyldopamine hydrochloride,
N,N-di-n-propyldopamine hydroiodide,
Dipropyldopamine hydrobromide,
65273-66-7,
N,N-Dipropyldopamine hydrobromide,
DPDA,
N,N-Dipropyldopamine,
EU-0100465,
SCHEMBL1321255,
CHEMBL1255747,
CTK5C2469,
DTXSID20474683,
QAXMCYJNFHCJFB-UHFFFAOYSA-N,
Tox21_500465,
N,N-di-n-propyldopamine hydrobromide,
CCG-221769,
LP00465,
NCGC00093878-01,
NCGC00261150-01,
D-031,
SR-01000075373,
SR-01000075373-1,
4-(2-Dipropylamino-ethyl)-benzene-1,2-diol hydrobromide,
3,4-dihydroxy-N,N-di-(n-propyl)phenethylamine hydrobromide,
1,2-Benzenediol,4-[2-(dipropylamino)ethyl]-, hydrobromide (1:1),
CID11957536,
4-[2-(dipropylamino)ethyl]benzene-1,2-diol,hydrobromide,
66185-61-3,